BlackRock Inc. - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 19 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$40,467
-48.8%
194,364
-13.9%
0.00%
Q1 2023$79,050
+63.6%
225,855
+0.5%
0.00%
Q4 2022$48,315
-38.8%
224,721
+0.3%
0.00%
Q3 2022$79,000
-73.8%
223,965
-0.4%
0.00%
Q2 2022$301,000
-33.7%
224,910
-0.3%
0.00%
Q1 2022$454,000
-25.9%
225,477
-0.7%
0.00%
Q4 2021$613,000
-26.8%
227,178
+16.3%
0.00%
Q3 2021$837,000
+67.7%
195,255
-0.3%
0.00%
Q2 2021$499,000
+0.2%
195,911
-4.8%
0.00%
Q1 2021$498,000
+42.3%
205,6840.0%0.00%
Q4 2020$350,000
-23.7%
205,6840.0%0.00%
Q3 2020$459,000
+60.5%
205,6840.0%0.00%
Q2 2020$286,000
+7.1%
205,6840.0%0.00%
Q1 2020$267,000
-46.2%
205,6840.0%0.00%
Q4 2019$496,000
+59.5%
205,6840.0%0.00%
Q3 2019$311,000
-10.1%
205,6840.0%0.00%
Q2 2019$346,000
-50.9%
205,6840.0%0.00%
Q1 2019$705,000
-33.0%
205,6840.0%0.00%
Q4 2018$1,053,000205,6840.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders